An old friend: 25 years of meloxicam use in Russia.
25 years ago, a new non-steroidal anti-inflammatory drug (NSAID) – meloxicam (Movalis®) – entered the clinical practice of our country. This drug was the first embodiment of the concept of selective blockade of cyclooxygenase 2 – the main pathway followed by pharmacological science to create a safe...
Saved in:
| Main Authors: | A. E. Karateev, E. L. Nasonov, E. Yu. Pogozheva, E. S. Filatova, V. N. Amirdzhanova, V. A. Nesterenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2021-07-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3042 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Meloxicam (movalis) in a physician's practice
by: Yuliya Leonidovna Korsakova, et al.
Published: (2011-09-01) -
New Gel Approaches for the Transdermal Delivery of Meloxicam
by: Ioana-Alexandra Plugariu, et al.
Published: (2025-06-01) -
Therapy with non-steroidal anti-inflammatory drugs and the quality of life of patients with rheumatic diseases
by: E. Yu. Polishchuk, et al.
Published: (2022-02-01) -
Use of meloxicam (amelotex®) in patients with gonarthrosis
by: Maksim Sergeevich Eliseev, et al.
Published: (2011-06-01) -
Factors influencing the efficacy of nonsteroidal anti-inflammatory drugs for acute low back pain. The results of the multicenter observational «CARAMBOL» (Clinical Analysis of Results of Analgesia by Meloxicam and its Safety in Acute Lumbodynia) study
by: A. E. Karateev, et al.
Published: (2019-05-01)